Journal

Mechanisms of Scarring in Focal Segmental Glomerulosclerosis

Read time: 1 mins

Published: 31st Aug 2021

Author: Sun K, Xie Q, Hao CM.

Source: Kidney Diseases

Availability: Free full text

Ref.: Kidney Dis (Basel). 2021 Sep;7(5):350-358.

DOI: 10.1159/000517108

Mechanisms of Scarring in Focal Segmental Glomerulosclerosis

Background: Focal segmental glomerulosclerosis (FSGS) is a histologic pattern characterized by focal glomerular scarring, which often progresses to systemic and diffuse glomerulosclerosis. Previous studies have emphasized that the initiation of classic FSGS occurs in podocytes. The dysfunction and loss of podocytes have been associated with the development of proteinuria and the progression of various diseases. In addition, primary, secondary, and genetic FSGS are caused by different mechanisms of podocyte injury.

Summary: The potential sources and mechanism of podocyte supplementation are the focus of our current research. Increasing attention has been paid to the role played by parietal epithelial cells (PECs) during the progression of FSGS. PECs are not only the primary influencing factors in glomerulosclerosis lesions but also have repair abilities, which remain a focus of debate. Notably, other resident glomerular cells also play significant roles in the progression of this disease.

Key message: In this review, we focus on the mechanism of scarring in FSGS and discuss current and potential therapeutic strategies.

Read abstract on library site Access full article

A blood draw being performed on the inside of a person's arm; testing for hyperkalaemia

Hyperkalemia

Disease information, latest news, and guidelines

A digital image of two human kidneys, stylised in blue and red

Chronic kidney disease

Expert insights on diagnosis and novel treatments

Digital close up of human kidney glomerulus and the Bowman Capsule

Glomerulonephritis

Unmet needs, latest news, and guideline updates

Featured Learning Zones

CMKD, Kidney disease, AI generated image

Learning Zone

Complement-Mediated Kidney Diseases (CMKDs) Learning Zone

Complement-mediated kidney diseases (CMKDs) are rare, chronic and progressive diseases. With this Learning Zone, explore and improve understanding of the role of complement in kidney disease and encourage earlier and optimal management of CMKDs.

You may be interested in...

Guideline

Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

The joint AAD–NPF guideline provides evidence‑based recommendations for the use of topical therapies and select alternative medicine approaches in psoriasis management. It offers updated guidance on severity assessment measures, treatment selection, and patient‑centred approaches to optimise outcomes in mild‑to‑moderate disease.

Guideline

French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025

These updated French guidelines provide new decision‑making algorithms for systemic treatment of moderate‑to‑severe psoriasis in adults. They incorporate recent evidence, integrate emerging systemic therapies, and offer recommendations for plaque psoriasis, psoriatic arthritis, comorbidities and special situations such as pregnancy.

Guideline

S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm - part 2: Specific clinical and comorbid situations

The EuroGuiDerm‑adapted S3 guideline part 2 provides recommendations for treating psoriasis vulgaris in patients with specific clinical presentations or comorbidities. It addresses management in pregnancy, infection risk, metabolic syndrome, organ‑specific disease, and difficult‑to‑treat areas, offering expert‑driven practical guidance.